SCGB3A2 and inflammation: Further, the anti-inflammatory activity of SCGB3A2 was demonstrated by the intranasal administration of recombinant adenovirus expressing SCGB3A2 to the OVA-induced inflammation model mouse, in which forced airway expression of SCGB3A2 suppressed OVA-induced airway inflammation [15].